DE60142340D1 - Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents

Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen

Info

Publication number
DE60142340D1
DE60142340D1 DE60142340T DE60142340T DE60142340D1 DE 60142340 D1 DE60142340 D1 DE 60142340D1 DE 60142340 T DE60142340 T DE 60142340T DE 60142340 T DE60142340 T DE 60142340T DE 60142340 D1 DE60142340 D1 DE 60142340D1
Authority
DE
Germany
Prior art keywords
heparin
polysaccharides
mixtures
preparation
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60142340T
Other languages
English (en)
Inventor
Jacques Diaz
Christelle Pecquet
Elisabeth Perrin
Christian Viskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60142340(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60142340D1 publication Critical patent/DE60142340D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE60142340T 2000-07-21 2001-07-18 Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen Expired - Lifetime DE60142340D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2001/002332 WO2002008295A1 (fr) 2000-07-21 2001-07-18 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DE60142340D1 true DE60142340D1 (de) 2010-07-22

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60142340T Expired - Lifetime DE60142340D1 (de) 2000-07-21 2001-07-18 Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen

Country Status (36)

Country Link
EP (1) EP1307491B2 (de)
JP (1) JP5279160B2 (de)
KR (1) KR100853585B1 (de)
CN (1) CN1230449C (de)
AP (1) AP1703A (de)
AR (1) AR029865A1 (de)
AT (1) ATE470679T1 (de)
AU (2) AU7760201A (de)
BR (1) BR0112612B1 (de)
CA (1) CA2416673C (de)
CL (1) CL2004001154A1 (de)
CY (1) CY1110774T1 (de)
DE (1) DE60142340D1 (de)
DK (1) DK1307491T3 (de)
DZ (1) DZ3411A1 (de)
EA (1) EA005995B1 (de)
EC (1) ECSP034442A (de)
ES (1) ES2347134T5 (de)
FR (1) FR2811992B1 (de)
HK (1) HK1059273A1 (de)
HR (1) HRP20030019A2 (de)
HU (1) HUP0300755A3 (de)
IL (2) IL153922A0 (de)
MA (1) MA26928A1 (de)
MX (1) MXPA03000579A (de)
NO (1) NO20030296L (de)
NZ (1) NZ524028A (de)
OA (1) OA12340A (de)
PL (1) PL202471B1 (de)
PT (1) PT1307491E (de)
SI (1) SI1307491T1 (de)
TW (1) TWI307278B (de)
UA (1) UA74836C2 (de)
WO (1) WO2002008295A1 (de)
YU (1) YU2903A (de)
ZA (1) ZA200300898B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ES2282368T3 (es) * 2002-06-20 2007-10-16 Chemi S.P.A. Procedimiento para la preparacion de esteres de heparina.
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
KR101104107B1 (ko) 2002-10-10 2012-01-12 아방티 파르마 소시에테 아노님 헤파린으로부터 유도된 다당류의 혼합물, 이의 제조방법 및이를 함유하는 약제학적 조성물
FR2845686B1 (fr) 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
WO2007140231A2 (en) * 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399591A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399592A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399590A1 (de) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
EP2399593A1 (de) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
EP2446891A1 (de) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin für Verwendung als eine antithrombotische Behandlung in den großen Bauchoperation mit verbesserter Sicherheit in Bezug auf klinisch relevante Blutungen und starken Blutungen
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2548561A1 (de) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin zur Verbesserung der Überlebenschancen von Patienten mit örtlich fortgeschrittenem Krebs
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
ES2161615B1 (es) 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.

Also Published As

Publication number Publication date
PT1307491E (pt) 2010-09-10
IL153922A0 (en) 2003-07-31
PL365561A1 (en) 2005-01-10
AU7760201A (en) 2002-02-05
PL202471B1 (pl) 2009-06-30
DK1307491T3 (da) 2010-10-11
BR0112612B1 (pt) 2011-07-12
EA200300178A1 (ru) 2003-06-26
EA005995B1 (ru) 2005-08-25
CN1447820A (zh) 2003-10-08
KR20030040364A (ko) 2003-05-22
EP1307491A1 (de) 2003-05-07
FR2811992B1 (fr) 2003-07-04
AR029865A1 (es) 2003-07-16
ZA200300898B (en) 2004-04-30
TWI307278B (en) 2009-03-11
YU2903A (sh) 2006-03-03
HUP0300755A2 (hu) 2003-12-29
AP1703A (en) 2007-02-26
MA26928A1 (fr) 2004-12-20
WO2002008295A1 (fr) 2002-01-31
CY1110774T1 (el) 2015-06-10
BR0112612A (pt) 2003-07-29
EP1307491B1 (de) 2010-06-09
DZ3411A1 (fr) 2002-01-31
CA2416673A1 (fr) 2002-01-31
JP5279160B2 (ja) 2013-09-04
HRP20030019A2 (en) 2005-10-31
ES2347134T5 (es) 2014-06-24
EP1307491B2 (de) 2014-05-07
HUP0300755A3 (en) 2004-03-01
MXPA03000579A (es) 2003-06-06
HK1059273A1 (en) 2004-06-25
CN1230449C (zh) 2005-12-07
ATE470679T1 (de) 2010-06-15
OA12340A (fr) 2006-05-15
ECSP034442A (es) 2003-03-10
SI1307491T1 (sl) 2010-10-29
CA2416673C (fr) 2011-06-14
NZ524028A (en) 2004-12-24
KR100853585B1 (ko) 2008-08-21
FR2811992A1 (fr) 2002-01-25
UA74836C2 (en) 2006-02-15
IL153922A (en) 2010-05-17
JP2004504451A (ja) 2004-02-12
NO20030296D0 (no) 2003-01-20
ES2347134T3 (es) 2010-10-26
AP2003002744A0 (en) 2003-03-31
NO20030296L (no) 2003-01-20
AU2001277602B2 (en) 2007-07-19
CL2004001154A1 (es) 2005-05-27

Similar Documents

Publication Publication Date Title
DE60142340D1 (de) Mischungen von polysacchariden aus heparin, deren herstellung und diese enthaltende pharmazeutische zubereitungen
DE60142890D1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
ATE250593T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
DE60138872D1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
BR0014465B1 (pt) 1,1'-bifenil-2-carbonamidas 2'-substituÍdas, preparado farmacÊutico e aplicaÇÕes dos referidos compostos.
EE04273B1 (et) Bensotsüklohepteenid, nende valmistamise meetod, neid sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
ATE193533T1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69519368T2 (de) Neue antiandrogenen mitteln pharmazeutische präparate und verwendungen davon
ATE204266T1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
PT1228039E (pt) N-guanidinoalquilamidas sua preparacao sua utilizacao e preparacoes farmaceuticas contendo as mesmas
DE69610085T2 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FR2807043B1 (fr) Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
ATE332140T1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
DE69907735D1 (de) Melatoninderivate und diese enthaltende pharmazeutische zubereitung
FR2809727B1 (fr) Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE60139306D1 (de) N-deacetylthiocolchin-derivate und diese enthaltende arzneimittel
FR2817257B1 (fr) Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
DE50008259D1 (de) Feste pharmazeutische zubereitungen mit nanosols aus chitosan, sowie deren herstellung

Legal Events

Date Code Title Description
8363 Opposition against the patent